Brief: RepliCel Secures New Patents For Its Regenerative Medicine Technologies
16/04/2019 12:46
April 16 (Reuters) - Replicel Life Sciences Inc RP.V :
* REPLICEL SECURES SEVERAL NEW PATENTS FOR ITS REGENERATIVE
MEDICINE TECHNOLOGIES
* REPLICEL LIFE SCIENCES-RECENTLY RECEIVED NOTIFICATIONS OF
MANY
PATENTS ISSUED, ALLOWED& GRANTED TO CO FROM EUROPE, CHINA, HONG
KONG, JAPAN, US, S.AFRICA
Source text for Eikon: ID:nPn2QxL0xa
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector